Background Cerebral palsy (CP) is the most common cause of physical disabilities in
children in highincome countries. Spasticity is the most common motor disturbance in CP …

» Children with cerebral palsy have muscles that are much smaller than muscles in typically
developing peers.» Injections of botulinum toxin type A (BoNT-A) result in acute muscle …

Background: Cerebral palsy (CP) is the most common cause of childhood disability globally.
Botulinum toxin A injections are widely used to manage limb spasticity in children with CP …

Aim To identify and map studies that have assessed the effect of interventions on lowerlimb
macroscopic muscle–tendon morphology in children with spastic cerebral palsy (CP) …

This review aims to determine the analgesic efficacy of botulinum toxin (BTX) for the
management of pain in children with cerebral palsy (CP). During July and August 2020, a …

Pain and quality of life are closely interrelated in children with cerebral palsy (CCP). Even
though 67% of CCP experience pain, it is overlooked and untreated. In this study, our …

Background Goal attainment scaling (GAS), an established individualized, patient-centred
outcome measure, is used to capture the patient's voice. Although first introduced~ 60 years …

Aim To describe the clinical course of pain intensity in individuals with cerebral palsy (CP)
resulting from usual care or specific interventions. Method We conducted an exploratory …

Background In spite of treadmill training and multilevel botulinum toxin (BoNT-A) injection
being the two most commonly used treatment methods in pediatric rehabilitation …

Background Different interventions are offered to children with cerebral palsy (CP) to
improve the activity domain of the international classification of functioning (ICF). In therapy …